Depression in dementia is common, disabling and causes significant distress to patients and
carers. Despite widespread use of antidepressants for depression in dementia, there is no …

Depression is the most frequent neuropsychiatric complication after traumatic brain injury
(TBI) and is associated with poorer outcomes. Neuroimaging has the potential to improve …

Genetic testing has evolved rapidly over recent years and new developments have the
potential to provide insights that could improve the ability to diagnose, treat, and prevent …

Objectives The present study introduces the assessment of depression and depressive
symptoms in the German National Cohort (NAKO), a population-based mega cohort …

Major depressive disorder (MDD) is a highly hetero-geneous diagnosis wherein the nine
MDD criterion signs and symptoms reflect 256 unique symptom combinations. 1 …

Depression can affect individuals' attitudes by enhancing cognitive biases and altering
perceptions of control. We investigate the relationship between depressive symptoms and …

Chronic stress is a major risk factor for psychiatric disorders, including depression. Although
depression is a highly heterogeneous syndrome, it remains unclear how chronic stress …

Abstract Major Depressive Disorder (MDD) has heterogeneous manifestations, leading to
difficulties in predicting the evolution of the disease and in patient's follow-up. We aimed to …

Major depressive disorder (MDD), also called depression, is a serious disease that impairs
the quality of life of patients and has a high incidence, affecting approximately 3.8% of the …

Major depressive disorder (MDD) is a complex and heterogeneous psychiatric syndrome
with genetic and environmental influences. In addition to neuroanatomical and circuit-level …